---
title: "Cinnamamide‑pyridine Quaternary Ammonium Derivative 9c Targets Bacterial Membranes Against Gram‑Po"
id: "pubmed-42361482"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42361482"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42361482/"
doi: "10.1016/j.ejmech.2026.119100"
published_at: "2026-11-05T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Cinnamamide‑pyridine Quaternary Ammonium Derivative 9c Targets Bacterial Membranes Against Gram‑Po
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42361482
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42361482/)
- **DOI:** [10.1016/j.ejmech.2026.119100](https://doi.org/10.1016%2Fj.ejmech.2026.119100)
- **Published At:** 2026-11-05T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The research team designed and synthesized a series of amphiphilic **cinnamamide‑pyridine** quaternary ammonium derivatives inspired by antimicrobial peptides. - Chemical optimization produced an optimal lead, **compound 9c**, a bis‑cationic molecule bearing hexyl chains. - In vitro antimicrobial testing showed potent activity against **Gram‑positive** pathogens with reported MICs of 0.5–1 μg/mL for 9c. - Safety metrics in the abstract included low hemolytic activity (HC50 = 482.4 μg/mL) and limited cytotoxicity (CC50 = 32.92 μg/mL). - Pharmacologic attributes noted in the report: strong plasma stability, rapid bactericidal kinetics, and a low propensity to select for resistance. - Antibiofilm activity was observed and described as strong; the compound also induced membrane depolarization and permeability changes in bacteria. - Mechanistic assays implicated a selective interaction with bacterial **phosphatidylglycerol**, triggering leakage of intracellular contents. - In a murine skin abscess model, investigators reported that 9c reduced bacterial burden and tissue inflammation and outperformed **vancomycin** in the measured endpoints. - The abstract states authors consider 9c a promising membrane‑active antibacterial candidate and recommend further development; specific in vivo dosing and full methodological details were not reported in the PubMed abstract. - The study declares no competing commercial interests and cites only public funding.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42361482/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42361482%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42361482/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42361482/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42361482/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42361482/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42361482/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42361482/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42361482%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42361482%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42361482/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42361482/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42361482/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42361482/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Elsevier Science full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--linkinghub.elsevier.com-ihub-images-PubMedLink.gif) Elsevier Science ](https://linkinghub.elsevier.com/retrieve/pii/S0223-5234\(26\)00545-3 "See full text options at Elsevier Science") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/42361482/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42361482/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42361482/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42361482/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42361482/#conflict-of-interest) * [Similar articles](https://pubmed.ncbi.nlm.nih.gov/42361482/#similar) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42361482/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42361482/#substances) * [Related information](https://pubmed.ncbi.nlm.nih.gov/42361482/#related-links) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/42361482/#linkout) Title & authors Abstract Conflict of interest statement Similar articles MeSH terms Substances Related information LinkOut - more resources Eur J Med Chem Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Eur+J+Med+Chem%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Eur+J+Med+Chem%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42361482/) . 2026 Nov 5:317:119100. doi: 10.1016/j.ejmech.2026.119100. Epub 2026 Jun 24. # Identification of novel cinnamamide-pyridine quaternary ammonium derivatives as membrane-targeting antibacterial agents against Gram-positive bacteria [Jinqian Liu](https://pubmed.ncbi.nlm.nih.gov/?term=Liu+J&cauthor_id=42361482)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42361482/#full-view-affiliation-1 "Medical School, Shandong Xiehe University, Jinan, 250109, China."), [Xinhao Dou](https://pubmed.ncbi.nlm.nih.gov/?term=Dou+X&cauthor_id=42361482)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42361482/#full-view-affiliation-2 "School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng, 252059, China."), [Zun Liu](https://pubmed.ncbi.nlm.nih.gov/?term=Liu+Z&cauthor_id=42361482)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42361482/#full-view-affiliation-2 "School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng, 252059, China."), [Chunhui Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+C&cauthor_id=42361482)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42361482/#full-view-affiliation-3 "Department of Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Electronic address: wangchunhui@email.sdfmu.edu.cn."), [Xiaoyan Wu](https://pubmed.ncbi.nlm.nih.gov/?term=Wu+X&cauthor_id=42361482)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42361482/#full-view-affiliation-4 "Medical School, Shandong Xiehe University, Jinan, 250109, China. Electronic address: xiaoyan1710@163.com."), [Yinhu Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+Y&cauthor_id=42361482)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42361482/#full-view-affiliation-5 "School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng, 252059, China. Electronic address: wangyinhuabc@126.com.") Affiliations Expand ### Affiliations * 1 Medical School, Shandong Xiehe University, Jinan, 250109, China. * 2 School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng, 252059, China. * 3 Department of Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Electronic address: wangchunhui@email.sdfmu.edu.cn. * 4 Medical School, Shandong Xiehe University, Jinan, 250109, China. Electronic address: xiaoyan1710@163.com. * 5 School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng, 252059, China. Electronic address: wangyinhuabc@126.com. * PMID: **42361482** * DOI: [ 10.1016/j.ejmech.2026.119100 ](https://doi.org/10.1016/j.ejmech.2026.119100) Item in Clipboard # Identification of novel cinnamamide-pyridine quaternary ammonium derivatives as membrane-targeting antibacterial agents against Gram-positive bacteria Jinqian Liu et al. Eur J Med Chem. 2026. Show details Display options Display options Format Abstract PubMed PMID Eur J Med Chem Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Eur+J+Med+Chem%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Eur+J+Med+Chem%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42361482/) . 2026 Nov 5:317:119100. doi: 10.1016/j.ejmech.2026.119100. Epub 2026 Jun 24. ### Authors [Jinqian Liu](https://pubmed.ncbi.nlm.nih.gov/?term=Liu+J&cauthor_id=42361482)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42361482/#short-view-affiliation-1 "Medical School, Shandong Xiehe University, Jinan, 250109, China."), [Xinhao Dou](https://pubmed.ncbi.nlm.nih.gov/?term=Dou+X&cauthor_id=42361482)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42361482/#short-view-affiliation-2 "School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng, 252059, China."), [Zun Liu](https://pubmed.ncbi.nlm.nih.gov/?term=Liu+Z&cauthor_id=42361482)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42361482/#short-view-affiliation-2 "School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng, 252059, China."), [Chunhui Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+C&cauthor_id=42361482)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42361482/#short-view-affiliation-3 "Department of Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Electronic address: wangchunhui@email.sdfmu.edu.cn."), [Xiaoyan Wu](https://pubmed.ncbi.nlm.nih.gov/?term=Wu+X&cauthor_id=42361482)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42361482/#short-view-affiliation-4 "Medical School, Shandong Xiehe University, Jinan, 250109, China. Electronic address: xiaoyan1710@163.com."), [Yinhu Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+Y&cauthor_id=42361482)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42361482/#short-view-affiliation-5 "School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng, 252059, China. Electronic address: wangyinhuabc@126.com.") ### Affiliations * 1 Medical School, Shandong Xiehe University, Jinan, 250109, China. * 2 School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng, 252059, China. * 3 Department of Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Electronic address: wangchunhui@email.sdfmu.edu.cn. * 4 Medical School, Shandong Xiehe University, Jinan, 250109, China. Electronic address: xiaoyan1710@163.com. * 5 School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng, 252059, China. Electronic address: wangyinhuabc@126.com. * PMID: **42361482** * DOI: [ 10.1016/j.ejmech.2026.119100 ](https://doi.org/10.1016/j.ejmech.2026.119100) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract The escalating crisis of antimicrobial resistance necessitates the development of novel antibacterial agents with distinct mechanisms of action. Inspired by the membrane-disruptive properties of antimicrobial peptides, a series of amphiphilic cinnamamide-pyridine quaternary ammonium derivatives were rationally designed and synthesized. The optimal derivative, compound 9c, featuring a bis-cationic scaffold with hexyl chains, exhibited potent and broad-spectrum antibacterial activity against Gram-positive pathogens (MICs = 0.5-1 μg/mL), along with good safety profiles characterized by low hemolytic activity (HC50 = 482.4 μg/mL) and low cytotoxicity (CC50 = 32.92 μg/mL). Other notable attributes included exceptional plasma stability, rapid bactericidal kinetics, a low tendency to induce resistance, and strong antibiofilm activity. Mechanistic investigations revealed that compound 9c selectively target bacterial membranes via specific interaction with phosphatidylglycerol, leading to membrane depolarization, increased permeability, and subsequent leakage of intracellular components. More importantly, 9c significantly reduced bacterial burden and mitigated tissue inflammation, outperforming vancomycin in a murine skin abscess model. Collectively, these findings establish 9c as a promising membrane-active antibacterial candidate worthy of further development. **Keywords:** Antibacterial agents; Antimicrobial resistance; Cinnamic acid derivatives; Membrane-active. Copyright © 2026 Elsevier Masson SAS. All rights reserved. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declaration of competing interest The authors declare that this study was carried out only with public funding. There is no funding or no agreement with commercial for profit firms. ## Similar articles * [ Development of Membrane-Targeting Cannabigerol Derivatives as Potent Broad-Spectrum Antibacterial Agents. ](https://pubmed.ncbi.nlm.nih.gov/41868181/) Yin Z, Zhang T, Wang Y, Wang Y, Xie X, Zhang F, Wang C, Hu W.Yin Z, et al.Drug Des Devel Ther. 2026 Jan 23;20:558606. doi: 10.2147/DDDT.S558606. eCollection 2026.Drug Des Devel Ther. 2026.PMID: 41868181Free PMC article. * [ An optimized 2,2'-dipicolylamine-rutaecarpine quaternary ammonium derivative: targeting bacterial membrane disruption for enhanced anti-methicillin-resistant Staphylococcus aureus (MRSA) activity. ](https://pubmed.ncbi.nlm.nih.gov/40680457/) Xu T, Wang T, Tian Y, Li X, Zhong Y, Liu J, Yang R, Guo Y.Xu T, et al.Eur J Med Chem. 2025 Nov 5;297:117975. doi: 10.1016/j.ejmech.2025.117975. Epub 2025 Jul 14.Eur J Med Chem. 2025.PMID: 40680457 * [ Development of membrane-targeting honokiol derivatives as antibacterial agents against gram-positive bacteria. ](https://pubmed.ncbi.nlm.nih.gov/41926794/) Liu J, Wu Y, Su X, Lv Y, Kong X, Li H, Wang Y.Liu J, et al.Bioorg Chem. 2026 Jul 5;175:109814. doi: 10.1016/j.bioorg.2026.109814. Epub 2026 Mar 29.Bioorg Chem. 2026.PMID: 41926794 * [ Development of novel bisphenol derivatives with a membrane-targeting mechanism as potent gram-positive antibacterial agents. ](https://pubmed.ncbi.nlm.nih.gov/38850855/) Zhong R, Xu Z, Zhang S, Zeng M, Li H, Liu S, Lin S.Zhong R, et al.Eur J Med Chem. 2024 Aug 5;274:116544. doi: 10.1016/j.ejmech.2024.116544. Epub 2024 May 31.Eur J Med Chem. 2024.PMID: 38850855 * [ Discovery of novel xanthotoxin-pyridine quaternary ammonium derivatives with membrane-targeting mode of action as potential antimicrobials against methicillin-resistant Staphylococcus aureus. ](https://pubmed.ncbi.nlm.nih.gov/40914015/) Xu S, Zhang M, Xie X, Tian Y, Wang Y, Wang X, Yang R, Guo Y.Xu S, et al.Eur J Med Chem. 2025 Dec 15;300:118139. doi: 10.1016/j.ejmech.2025.118139. Epub 2025 Sep 4.Eur J Med Chem. 2025.PMID: 40914015 [ See all similar articles ](https://pubmed.ncbi.nlm.nih.gov/?linkname=pubmed_pubmed&from_uid=42361482) ## MeSH terms * Animals Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Animals%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Animals) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42361482/) * Anti-Bacterial Agents* / chemical synthesis Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Anti-Bacterial+Agents%2Fchemical+synthesis%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Anti-Bacterial+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42361482/) * Anti-Bacterial Agents* / chemistry Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Anti-Bacterial+Agents%2Fchemistry%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Anti-Bacterial+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42361482/) * Anti-Bacterial Agents* / pharmacology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Anti-Bacterial+Agents%2Fpharmacology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Anti-Bacterial+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42361482/) * Cell Membrane* / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell+Membrane%2Fdrug+effects%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cell+Membrane) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42361482/) * Cinnamates* / chemistry Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cinnamates%2Fchemistry%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cinnamates) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42361482/) * Cinnamates* / pharmacology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cinnamates%2Fpharmacology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cinnamates) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42361482/) * Dose-Response Relationship, Drug Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Dose-Response+Relationship%2C+Drug%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Dose-Response+Relationship%2C+Drug) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42361482/) * Gram-Positive Bacteria* / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Gram-Positive+Bacteria%2Fdrug+effects%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Gram-Positive+Bacteria) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42361482/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date
## Related Clinical Research

- [Bacterial profile and mortality predictors in necrotizing fasciitis — multicentre Uganda study](https://medichelpline.com/clinical-feed/pubmed-43049839.md) (DOI: 10.1007/s15010-026-02767-1)
- [Spermine–NSAID Conjugate RNP-11 Shows Potent Activity Against MRSA and VRE](https://medichelpline.com/clinical-feed/pubmed-42531897.md) (DOI: 10.1016/j.ejmech.2026.119181)
- [Anti‑phage defense genes mapped in vancomycin‑resistant Enterococcus faecium genomes](https://medichelpline.com/clinical-feed/biorxiv-2-functional-genomic-characterization-of-anti-phage-defense-systems-in-vancomycin.md)
- [PharmaAgent real-world test: high- vs low-autonomy agents for inpatient vancomycin dosing](https://medichelpline.com/clinical-feed/medrxiv-0-pharmaagent-a-real-world-evaluation-of-high-and-low-autonomy-agentic-systems.md)
- [Antibiotic‑Resistant and Heavy Metal–Tolerant Bacteria in Batissa violacea from Fiji’s Ba River](https://medichelpline.com/clinical-feed/plos-one-20-antibiotic-resistant-pathogens-and-heavy-metal-tolerant-bacteria-in-batissa.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.